Elanco Animal Health Incorporated

Elanco Animal Health NYSE: ELAN raised its full-year outlook after third-quarter revenue rose 11%, driven by demand for its pet health products Zenrelia and Credelio Quattro and higher prices across its portfolio.

Elanco Animal Health Incorporated ( ELAN ) Q3 2026 Earnings Call November 6, 2026 8:00 AM EST Company Participants Tiffany Kanaga - VP of Investor Relations & ESG Jeffrey Simmons - President, CEO & Director Robert VanHimbergen - Executive VP & CFO Conference Call Participants Jonathan Block - Stifel, Nicolaus & Company, Incorporated, Research Division Glen Santangelo - Barclays Bank PLC, Research Division Matthew Dellatorre - Goldman Sachs Group, Inc., Research Division Erin Wilson Wright - Morg…

Elanco Animal Health Incorporated (NYSE:ELAN) delivered better-than-expected third-quarter financial results on strong demand and higher prices.

The headline numbers for Elanco Animal Health (ELAN) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Elanco Animal Health Incorporated (ELAN) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.19 per share a year ago.

Accelerated Price, Organic Constant Currency Revenue Growth, and Gross Margin Expansion; Raising Full Year Outlook and Innovation Target; Achieved 2.9x Net Leverage Ratio Milestone Third Quarter 2026 Financial Results: Revenue of $1.265 billion, an increase of 11% year-over-year; 9% organic constant currency growth Reported Net Income of $18 million, Adjusted Net Income of $136 million Adjusted EBITDA of $243 million; Adjusted EBITDA Margin of 19.5% Reported EPS of $0.04, Adjusted EPS of $0.27 N…

Latest U.S. Survey of 2,000+ Consumers Shows 93% of Pet Owners Maintained or Increased Pet Spending in Past Three Months, Omnichannel Shift Redefines Purchasing INDIANAPOLIS, Nov. 6, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN), today released findings from its latest U.S. consumer research, demonstrating that pet owners continue to fiercely protect health spending for their pets, affirming expectations for enduring strength of the animal health sector.  According to the n…

One stock has soared more than sevenfold this year, another just lost a quarter of its value on leaked data, and a third carries the fate of millions of retirees. Friday's earnings could test each rally in very different ways.

INDIANAPOLIS, Nov. 3, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the UBS Global Healthcare Conference on November 9, 2026. Bob VanHimbergen, executive vice president and CFO, and Bobby Modi, executive vice president U.S. Pet Health and Global Digital Transformation will participate in a fireside chat on Monday, November 9 at 1:15 p.m.

Elanco Animal Health (ELAN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Preston brings more than two decades of global HR leadership and workforce innovation experience; Dave Kinard to retire at year-end INDIANAPOLIS, Oct. 22, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced the appointment of Jamie Preston as Executive Vice President and Chief People Officer, effective November 3rd. Preston's appointment follows an extensive and competitive search as part of the company's commitment to attract, develop and retain an engaged global…

Apple just got cut, BlackRock got a lift, and chipmakers are under pressure ahead of a week packed with big-tech earnings. Find out which stocks Wall Street is moving on Tuesday and why the calls matter right now.

Elanco Animal Health Incorporated (NYSE: ELAN - Get Free Report) insider Timothy Bettington sold 4,350 shares of Elanco Animal Health stock in a transaction on Thursday, October 15th. The shares were sold at an average price of $23.00, for a total transaction of $100,050.00. Following the completion of the transaction, the insider directly owned 138,911 shares

Elanco Animal Health (ELAN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Elanco Animal Health NYSE: ELAN President and CEO Jeff Simmons outlined the company's growth strategy, product launches, deleveraging plans and outlook for its pet health and farm animal businesses during the Bank of America Healthcare Conference in London.

State Street Corp grew its holdings in Elanco Animal Health Incorporated (NYSE: ELAN) by 4.7% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 16,063,046 shares of the company's stock after purchasing an additional 726,567 shares during the quarter. State Street Corp owned

Elanco Animal Health Incorporated (ELAN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Elanco Animal Health (NYSE: ELAN - Get Free Report) and Amarin (NASDAQ: AMRN - Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings. Volatility and Risk Elanco Animal Health has a

Corient Private Wealth LP lifted its position in shares of Elanco Animal Health Incorporated (NYSE: ELAN) by 124.1% during the undefined quarter, according to its most recent disclosure with the SEC. The firm owned 342,271 shares of the company's stock after buying an additional 189,540 shares during the period. Corient Private Wealth LP

INDIANAPOLIS, Sept. 17, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the BofA Securities Global Healthcare Conference 2026 on September 22, 2026.